US Broker Ratings

Medpace Holdings, Inc. (MEDP) Stock Analysis: Evaluating the Healthcare Giant’s Growth Potential

Medpace Holdings, Inc. (NASDAQ: MEDP) stands as a prominent player in the healthcare sector, specifically within the diagnostics and research industry. Headquartered in Cincinnati, Ohio, Medpace offers a comprehensive range..

Viatris Inc. (VTRS) Stock Analysis: Evaluating the Healthcare Giant’s 9.60% Potential Upside for Investors

Viatris Inc. (NASDAQ: VTRS), a prominent player in the healthcare sector, stands out as a compelling investment opportunity with a notable potential upside of 9.60%. Headquartered in Canonsburg, Pennsylvania, Viatris..

West Pharmaceutical Services (WST) Stock Analysis: Unveiling a Potential 19% Upside in the Healthcare Sector

West Pharmaceutical Services, Inc. (NYSE: WST) stands as a prominent player in the healthcare sector, specifically within the medical instruments and supplies industry. With a market capitalization of $23.93 billion,..

CVS Health Corporation (CVS) Stock Analysis: Exploring a Potential 19.95% Upside for Investors

Investors eyeing opportunities within the healthcare sector might find CVS Health Corporation (NYSE: CVS) an intriguing prospect. With a substantial market capitalization of $123.73 billion, CVS stands as a prominent..

Intuitive Surgical, Inc. (ISRG) Stock Analysis: A 30% Upside Potential Beckons Investors

Intuitive Surgical, Inc. (NASDAQ: ISRG), a leader in the healthcare sector specializing in medical instruments and supplies, presents a compelling opportunity for investors. With a market capitalization of $131.38 billion,..

Alnylam Pharmaceuticals, Inc. (ALNY) Stock Analysis: A 39% Upside Potential Amid Robust Revenue Growth

Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY), a leader in the biotechnology sector, has been capturing investor attention with its innovative approach to therapeutics based on ribonucleic acid interference (RNAi). Headquartered in..

Incyte Corporation (INCY) Stock Analysis: Riding High on a 37.7% Revenue Growth Surge

Incyte Corporation (NASDAQ: INCY), a prominent player in the biotechnology industry, is captivating investor attention with its robust revenue growth and a promising pipeline of therapeutics. As the healthcare sector..

BioMarin Pharmaceutical Inc. (BMRN) Stock Analysis: 37% Upside Potential Amid Robust Revenue Growth

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN), a leading biotechnology company based in San Rafael, California, is captivating investor interest with its focus on developing and commercializing therapies for rare diseases. With..

Waters Corporation (WAT) Stock Analysis: Revenue Growth Surges 113.4%, Analyst Ratings Favorable

Waters Corporation (NYSE: WAT), a prominent player in the healthcare sector, continues to capture the attention of investors with its impressive revenue growth and favorable analyst ratings. Headquartered in Milford,..

BeOne Medicines Ltd. (ONC) Stock Analysis: Unveiling a 20% Upside Potential in the Biotech Sector

In the ever-dynamic landscape of biotechnology, BeOne Medicines Ltd. (NASDAQ: ONC) has emerged as a promising entity, creating buzz among investors with its robust pipeline and innovative cancer treatments. Based..

Fresenius Medical Care AG (FMS) Stock Analysis: Navigating Growth with a 14% Upside Potential

Fresenius Medical Care AG (NYSE: FMS) stands as a pivotal player in the healthcare sector, specializing in dialysis services and products critical for individuals battling renal diseases. As the world’s..

Sanofi (SNY) Stock Analysis: Navigating a 21% Upside Potential Amidst Robust Revenue Growth

Sanofi (SNY), a global leader in the healthcare sector, is a powerhouse in the drug manufacturing industry. With a substantial market capitalization of $106.01 billion, this French company is making..

Align Technology, Inc. (ALGN)

⚠️ No article content returned.

..

STERIS plc (STE) Stock Analysis: Navigating a 17% Potential Upside in the Medical Devices Sector

Investors eyeing opportunities in the healthcare sector may find STERIS plc (NYSE: STE) a compelling consideration, especially given its position within the medical devices industry. With a market capitalization of..

Illumina, Inc. (ILMN) Stock Analysis: Navigating Growth Amid Market Volatility

Illumina, Inc. (NASDAQ: ILMN) remains a cornerstone in the healthcare sector, specifically within the diagnostics and research industry. With a market capitalization of $32.95 billion, the San Diego-based company is..

Tenet Healthcare Corporation (THC) Stock Analysis: Unpacking the 7.56% Upside Potential

Tenet Healthcare Corporation (NYSE: THC), a formidable player in the healthcare sector, has piqued investor interest with its promising upside potential. With a market capitalization of $21.34 billion, this Dallas-based..

AbbVie Inc. (ABBV) Stock Analysis: Exploring Growth Potential Amidst a Solid 7.85% Upside

AbbVie Inc. (NYSE: ABBV), a major player in the healthcare sector, continues to capture investor interest, thanks to its robust portfolio and promising financial outlook. With a market capitalization of..

Royalty Pharma plc (RPRX) Stock Analysis: Navigating Growth with a 16.5% Revenue Surge

Royalty Pharma plc (NASDAQ: RPRX) stands at the intersection of finance and pharmaceuticals, offering a unique value proposition for investors keen on the healthcare sector. With a robust market capitalization..

United Therapeutics Corporation (UTHR) Stock Analysis: Insights on a 36.24% Potential Upside

United Therapeutics Corporation (NASDAQ: UTHR), a prominent player in the healthcare sector focusing on specialty and generic drug manufacturing, presents a compelling investment case with its significant potential upside and..

Centene Corporation (CNC) Stock Analysis: Navigating Healthcare Challenges with a 6.90% Upside Potential

Centene Corporation (NYSE: CNC) is a formidable player in the healthcare sector, specializing in managed care services that cater to under-insured families and commercial organizations across the United States. With..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds